Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

The New England Journal of Medicine
H J AlterG Kuo

Abstract

We measured antibody (anti-HCV) to hepatitis C virus, which causes non-A, non-B hepatitis, by radioimmunoassay in prospectively followed transfusion recipients and their donors. Of 15 patients with chronic non-A, non-B hepatitis documented by liver biopsy, all seroconverted for the antibody; of 5 with acute resolving non-A, non-B hepatitis, 3 (60 percent) seroconverted. The development of anti-HCV was delayed (mean delay, 21.9 weeks after transfusion, or 15 weeks after the onset of clinical hepatitis) and took approximately one year in one patient. Antibody has persisted in 14 of the 15 patients with chronic disease (mean follow-up, greater than or equal to 6.9 years; maximum, greater than or equal to 12), but has disappeared in the 3 with acute resolving disease after a mean of 4.1 years. Anti-HCV was detected in samples of donor serum given to 14 (88 percent) of the 16 anti-HCV-positive patients for whom all donor samples were available. Only 33 percent of the anti-HCV-positive donors tested had an elevated serum concentration of alanine aminotransferase; 54 percent were positive for antibody to the hepatitis B core antigen (anti-HBc). We conclude that hepatitis C virus is the predominant agent of transfusion-associated non-A...Continue Reading

References

Jan 13, 1977·The New England Journal of Medicine·J W MosleyR H Purcell
Aug 1, 1983·The Journal of Infectious Diseases·D W BradleyH A Fields
Aug 7, 1981·JAMA : the Journal of the American Medical Association·H J AlterD E Koziol

❮ Previous
Next ❯

Citations

Jun 13, 1998·American Journal of Hematology·R L PaquetteJ B Zeldis
Sep 1, 1996·Journal of Medical Virology·S SchleicherB Flehmig
Jan 1, 1996·Journal of Clinical Laboratory Analysis·D LavanchyP C Frei
Jun 22, 2000·Proteins·A T YagnikA Tramontano
Jan 1, 1993·American Journal of Hematology·H F Bunn
Sep 1, 1993·American Journal of Hematology·L M Aledort
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R BurioniM Clementi
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K IshiiT Miyamura
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Cerny, F V Chisari
Jan 1, 1994·Journal of Clinical Laboratory Analysis·R A McPherson
Dec 1, 1990·Journal of Medical Virology·A M BrindM F Bassendine
Dec 1, 1990·Journal of Medical Virology·L A EllisG M Dusheiko
Feb 1, 1991·Journal of Medical Virology·K C HyamsM C McCarthy
Jun 1, 1991·Journal of Medical Virology·J K DaleS E Straus
Jul 1, 1991·Journal of Medical Virology·C J TibbsJ E Banatvala
Sep 1, 1991·Journal of Medical Virology·G J van DoornumR A Coutinho
Jun 1, 1992·Journal of Medical Virology·M RapicettaF Goffredo
Jun 1, 1992·Journal of Medical Virology·J C SheuD S Chen
Jul 1, 1992·Journal of Medical Virology·D BrestersP N Lelie
Jul 1, 1992·Journal of Medical Virology·T C LiouH L Wu
Jul 1, 1992·Journal of Medical Virology·V CarreñoI Castillo
Aug 1, 1992·Journal of Medical Virology·K C HyamsM Carl
Aug 1, 1992·Journal of Medical Virology·E Puchhammer-StöcklC Kunz
Apr 1, 1993·Journal of Medical Virology·E SuzukiS Sasaoka
May 1, 1993·Journal of Medical Virology·M Y KuoD S Chen
Jun 1, 1993·Journal of Medical Virology·T T ChangH L Wu
Sep 1, 1993·Journal of Medical Virology·J D CallahanJ Bansal
Jan 1, 1994·Journal of Medical Virology·B M McFarlaneI G McFarlane
Feb 1, 1994·Journal of Medical Virology·W B BarhamK C Hyams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.